An Interactive Text-Message Based Brief Intervention to Reduce Substance-Impaired Driving Among College Students
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03496129 |
|
Recruitment Status :
Completed
First Posted : April 12, 2018
Last Update Posted : October 6, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Alcohol-Impaired Driving | Behavioral: Personalized feedback Behavioral: Personalized feedback and text messages Behavioral: Information Only | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 116 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Evaluation of an Interactive Text-Message Based Brief Intervention to Reduce Substance-Impaired Driving Among College Students |
| Actual Study Start Date : | September 22, 2018 |
| Actual Primary Completion Date : | April 30, 2021 |
| Actual Study Completion Date : | April 30, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Personalized Feedback
Following the baseline assessment, participants will be sent a link via text message to a secure website containing substance-impaired driving specific personalized feedback. Feedback will include the following elements: a personalized substance use profile and substance-impaired driving profile, information on social norms related to substance use and substance-impaired driving, personalized information on BAC (or level of impairment due to drug use) prior to driving, costs associated with a DUI citation in Kentucky, and information on combined drug and alcohol impaired driving risk (if endorsed).
|
Behavioral: Personalized feedback
Following the baseline assessment, participants will be sent a link via text message to a secure website containing substance-impaired driving specific personalized feedback. Feedback will include the following elements: a personalized substance use profile and substance-impaired driving profile, information on social norms related to substance use and substance-impaired driving, personalized information on BAC (or level of impairment due to drug use) prior to driving, costs associated with a DUI citation in Kentucky, and information on combined drug and alcohol impaired driving risk (if endorsed). |
|
Experimental: Personalized feedback and text messages
Following the baseline assessment, participants will be sent a link via text message to a secure website containing substance-impaired driving specific personalized feedback (described above). Participants will be asked to send a text message back to the study administrator after viewing the feedback document. After confirming receipt and processing of the document, the study administrator will then send the participant three text messages containing open-ended questions.
|
Behavioral: Personalized feedback and text messages
Experimental: Personalized feedback and text messages Following the baseline assessment, participants will be sent a link via text message to a secure website containing substance-impaired driving specific personalized feedback (described above). Participants will be asked to send a text message back to the study administrator after viewing the feedback document. After confirming receipt and processing of the document, the study administrator will then send the participant three text messages containing open-ended questions. |
|
Active Comparator: Information Only
Students randomized to the information condition will receive standard information about alcohol and other drugs and substance-impaired driving via a link to a website delivered through text message.
|
Behavioral: Information Only
Active Comparator: Information Only Students randomized to the information condition will receive standard information about alcohol and other drugs and substance-impaired driving via a link to a website delivered through text message. |
- Change in number of times driving after using substances [ Time Frame: 3 months, 6 months, 1 year ]Participants will be asked to report the number of times they have driven within two hours of drinking alcohol or using other substances.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18 or older
- Currently enrolled (full or part-time) in college
- Ability to speak, read, and write in English
- Reports driving after drinking two or more drinks prior to driving at least three times in the past three months AND/OR reports driving after using marijuana or any other substance prior to driving at least three times in the past three months
- Reports having access to a motor vehicle, a valid driver's license, and plans to drive a vehicle in the next 3 months
- Reports access to a cell phone and willingness to read intervention material and exchange 3 texts post intervention with the study administrator
- Reports a valid email address
Exclusion Criteria:
- Currently in treatment for substance use or abuse
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03496129
| United States, Kentucky | |
| Gary Ransdell Hall | |
| Bowling Green, Kentucky, United States, 42101 | |
| Principal Investigator: | Jenni B Teeters, PhD | Western Kentucky University |
| Responsible Party: | Western Kentucky University |
| ClinicalTrials.gov Identifier: | NCT03496129 |
| Other Study ID Numbers: |
18-187 |
| First Posted: | April 12, 2018 Key Record Dates |
| Last Update Posted: | October 6, 2021 |
| Last Verified: | October 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

